IDIVX
Price
$22.83
Change
+$0.03 (+0.13%)
Updated
Jun 18 closing price
Net Assets
753.36M
RMFEX
Price
$62.81
Change
+$0.30 (+0.48%)
Updated
Jun 18 closing price
Net Assets
116.64B
Interact to see
Advertisement

IDIVX vs RMFEX

IDIVX vs RMFEX Comparison Chart in %
View a ticker or compare two or three
VS
IDIVX vs. RMFEX commentary
Jun 19, 2026

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is IDIVX is a Hold and RMFEX is a Hold.

Interact to see
Advertisement
FUNDAMENTALS
Fundamentals
RMFEX has more cash in the bank: 117B vs. IDIVX (753M). IDIVX pays higher dividends than RMFEX: IDIVX (2.39) vs RMFEX (1.45). IDIVX was incepted earlier than RMFEX: IDIVX (14 years) vs RMFEX (24 years). IDIVX (1.40) is less costly to investors than RMFEX (0.62). RMFEX is a more actively managed with annual turnover of: 30.00 vs. IDIVX (27.86). RMFEX has a lower initial minimum investment than IDIVX: RMFEX (250) vs IDIVX (1000). IDIVX annual gain was more profitable for investors over the last year : 25.05 vs. RMFEX (10.20). IDIVX return over 5 years is better than : 79.83 vs. RMFEX (39.81).
IDIVXRMFEXIDIVX / RMFEX
Total Expense Ratio0.950.62153%
Annual Report Gross Expense Ratio1.400.62226%
Fund Existence14 years24 years-
Gain YTD14.7066.326232%
Front Load5%N/A-
Min. Initial Investment1000250400%
Min. Initial Investment IRAN/AN/A-
Net Assets753M117B1%
Annual Yield % from dividends2.391.45165%
Returns for 1 year25.0510.20246%
Returns for 3 years55.2133.74164%
Returns for 5 years79.8339.81201%
Returns for 10 years129.16101.94127%
View a ticker or compare two or three
Interact to see
Advertisement
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
MFs / NAMEPrice $Chg $Chg %
IAFMX21.29-0.18
-0.84%
F/m Investments Large Cap Focused Inv
CDVZX20.48-0.20
-0.96%
Columbia Intrinsic Value Institutional
VDSCX21.15-0.21
-0.98%
Victory Diversified Stock C
JRASX89.72-1.04
-1.15%
Janus Henderson Research S
GSUTX66.33-0.85
-1.27%
Goldman Sachs US Equity Insights Inv